Welcome to the fifth meeting of the Medicon Valley Alliance R&D Network on 24th of November.
The Medicon Valley Alliance R&D Network invites you to join the discussion on the importance of drug delivery in developing new medicines and how we can enhance future collaborations in the region within this field.
New innovations within drug delivery can create evident value for patients, for our society and for the life science industry with more effective and safe treatments, more convenient delivery modalities leading to better patient adherence to medication as well as new business opportunities and job creation. Looking into the future we have tremendous opportunities, but also some challenges, and it is therefore of great importance that we stay innovative and entrepreneurial.
The meeting, hosted by Sweden Drug Delivery Industry Group, will give you an overview of what is currently trending in drug delivery, from academic and industry point of view. The speakers will also engage in a panel discussion with focus on growing, and developing, the current pool of competences in the Øresund region within this field.
The Øresund region is home to great innovation in drug delivery and with advanced academic research centres as well as small and large sized companies, working on novel methods, tailoring of existing drug delivery systems and developing advanced assessment tools.
Due to the current Covid-19 situation in Denmark and Sweden this meeting is delivered in a shorter webinar format instead of a regular networking meeting.
| Date: | 24 November, 2020 |
| Time: | 15:00-16:30 |
| Host: | Sweden Drug Delivery Industry Group |
| Venue: | Online |
Video recording
Program
| Moderator: Anna Stenstam, CR Competence | |
| 14.50-15.00 | Online platform open for connecting participants |
| 15.00-15.05 | Welcome and Introduction to Trends in Drug Delivery Petter Hartman, CEO, Medicon Valley Alliance Anna Stenstam, CR Competence Download presentation (PDF) |
| 15.05-15.10 | Strategic use of drug formulation patents Jens Viktor Nørgaard, Partner, Head of Biotechnology & Plant Sciences, European Patent Attorney, Høiberg Download presentation (PDF) |
| 15.10-15.20 | Sweden Drug Delivery Industry Group and drug delivery at AstraZeneca Jonas Johansson, Director of Science and Innovation, Astra Zeneca R&D Download presentation (PDF) |
| 15.20-15.30 | Viscosity Reducing Agents Dr. Tobias Rosenkranz, Head of Biomolecule Liquid Formulation, Liquid Formulation R&D, Merck Group |
| 15.30-15.40 | Drug Delivery developments at Ferring Pharmaceuticals Andreas Hugerth, Senior Scientist, Product Development and Drug Delivery, Global Pharmaceutical R&D, Ferring Pharmaceuticals A/S Download presentation (PDF) |
| 15.40-15.50 | A new drug delivery technology – From lab to commercial product Nils-Ove Gustafsson, VP Late Stage Development, Camurus AB Download presentation (PDF) |
| 15.50-16.00 | LEO Foundation Center for Cutaneous Drug Delivery Martin Malmsten, Professor, University of Copenhagen Download presentation (PDF) |
| 16.00-16.10 | Biobarriers – Health, Disorders and Healing Johan Engblom, Professor, Biofilms – Research Center for Biointerfaces, Malmö University Download presentation (PDF) |
| 16.10-16.25 | Panel discussion: Potential areas for collaboration in Medicon Valley Moderated by Anna Stenstam |
| 16.25-16.30 | Final remarks and conclusions Jonas Johansson, Director of Science and Innovation, AstraZeneca R&D & Jörn Mars, Senior Account Manager, Merck Chemicals and Life Science AB |
For more information please contact Sofia Norås sn@mva.org
The MVA R&D Network
The Medicon Valley Alliance R&D Network is a professional and social network for C-level R&D executives (CSOs, CMOs, VPs), university professors and PIs, and top-level managers in the hospital sector. The network focuses on sharing best practice and experiences, as well as discussing current challenges for industry-academia collaboration and the commercialization of R&D in the Medicon Valley region, such as how we can strengthen collaboration and knowledge-sharing between academia and industry to stimulate start-up, scale-up, commercialization and growth and wat is required to turn great science into successful innovations.
Joining the network is free of charge but is limited to Medicon Valley Alliance members. Non-member organizations and companies are welcome to attend one network event to evaluate the relevance in joining the network.
| Hosted by: | |
 |
| MVA R&D Network is managed by | Sponsored by | |
 |
 |
| In collaboration with | |
 |
 |